STAA - STAAR Surgical Company

https://www.staar.com

Sell Momentum: Bearish

Recent News

Johnson Fistel Investigates Fairness of Proposed Sale of STAAR Surgical - Staar Surgical ( NASDAQ:STAA ) , Alcon ( NYSE:ALC )

Benzinga • 5 days, 21 hours ago • score: 0.41

SAN DIEGO, Sept. 09, 2025 ( GLOBE NEWSWIRE ) -- Shareholder rights law firm Johnson Fistel, PLLP continues its investigation into whether the board members of STAAR Surgical Company STAA breached their fiduciary duties in connection with the proposed sale of the Company to Alcon ALC.

Bullish

This Campbell's Analyst Is No Longer Bullish; Here Are Top 5 Downgrades For Thursday - The Campbell's ( NASDAQ:CPB ) , Fortinet ( NASDAQ:FTNT )

Benzinga • 1 month, 1 week ago • score: 0.15

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiations, please see our analyst ratings page. Guggenheim analyst Howard Ma downgraded Informatica Inc INFA from Buy to Neutral and ...

Interval:

EMA1: EMA2:

AI Tools

Key Metrics

Trend: Range-Bound

As of 2025-09-10 (Snapshot)

STAAR Surgical Company designs, develops, manufactures, markets and sells implantable eye lenses and supplemental delivery systems for placing the lenses in the eye. The company is headquartered in Lake Forest, California.

52W High

$38.60

52W Low

$13.50

MA Status:

50D: Above 200D: Above

Beta (~1 neutral, <0.9 lower risk)

0.75

Valuation

Rich

As of 2025-06-30 (Overview)

Trailing P/E (<15 better)

N/A

Forward P/E (<15 better)

63.69

EV/EBITDA (<8 favorable)

42.84

EV/Revenue (<3 favorable)

5.50

P/S (TTM) (<3 favorable)

6.17

P/B (<3 favorable)

4.11

Ownership

Institution‑heavy

Source: Overview

Insiders (1–5% typical)

0.56%

Institutions (25–75% balanced)

110.90%

Shares Outstanding

49,553,000

Float

29,976,100

Dividend Yield (2–6% sweet spot)

N/A

Ex‑Dividend Date

N/A

Income & Growth

Profitability: Weak

As of 2025-06-30 (Overview)

Revenue (TTM)

224,449,000

Gross Profit (TTM)

160,939,000

EPS (TTM)

-1.93

Profit Margin (>10% good)

-0.42%

Operating Margin (TTM) (higher better)

-0.56%

ROE (TTM) (>15% strong)

-0.26%

EPS YoY (Quarterly) (>10% good)

1.02

Revenue YoY (Quarterly) (>8% good)

-0.55

Momentum

Bearish momentum

Value

1.1326

1.2234

Trend

Falling

Signal Cross

No cross

As of

Sep. 12, 2025